October 8, 2019 | Vensana in the News

Medtech investor duo seeks to ‘fill the gap’ in device sector private funding

21

Novel FDA PMA & de novo 510k approvals

60

U.S. Commercial Product Launches

39

Level I Clinical Trials

31

Strategic Financings

31

Exits by IPO or M&A